Quality Regulations: Unterschied zwischen den Versionen

Aus cannabis.gmpvintern.de
Zur Navigation springen Zur Suche springen
 
Zeile 36: Zeile 36:
 
MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020
 
MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020
  
−
[https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials MHRA Guidance]
+
[https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials MHRA Guidance] (website)
 +
 
 +
[https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/869284/Cannabis_Guidance__unlicensed_CBPMs__updated_2020.pdf The supply of unlicensed cannabis-based products for medicinal use in humans], 2020 (document)
 +
 
 +
[https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/373505/The_supply_of_unlicensed_medicinal_products__specials_.pdf The supply of unlicensed medicinal products 'specials", MHRA Guidance Note 14], 2014 (document)

Aktuelle Version vom 18. Oktober 2021, 14:07 Uhr

Scope[Bearbeiten]

Regulations for Cultivation & Collection[Bearbeiten]

WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Link to WHO)

WHO GACP Guideline

Regulations for Processing, Packaging and Storage[Bearbeiten]

Requirements Health Canada[Bearbeiten]

Health Canada's Cannabis Regulations SOR/2018-144 requires surveillance of the premises in section 64-66.

HC Cannabis Regulations

GAP Canada Version (current Version 9.0 – April 1, 2021) A revision is usually done in February each year.

GAP Canada V 9.0

Health Canada; Good Manufacturing Practices (GUI-0001); July 1, 2020

HC GMP 2020

European Union[Bearbeiten]

Reflection paper on microbiological aspects of herbal medicinal products and traditional herbal medicinal products

EMA Reflection paper

Application requirements for cannabis cultivation, processing and medical sales licences[Bearbeiten]

Requirements Health Canada[Bearbeiten]

Application requirements for cannabis cultivation, processing and medical sales licences

United Kingdom (UK)[Bearbeiten]

MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020

MHRA Guidance (website)

The supply of unlicensed cannabis-based products for medicinal use in humans, 2020 (document)

The supply of unlicensed medicinal products 'specials", MHRA Guidance Note 14, 2014 (document)